C3i was present at Advanced Therapy Week 2026

Our team was present at Advances Therapies Week in San Diego on February 9-12th, 2026.

Our takeaway is these six major key subjects the industry is clearly aligned on right now:

1. 1. Standardization & automation are the number 1 priority. Closed systems, modular processes, digital batch records. Variability that the field can control is no longer acceptable.
   2. CDMOs are strategic partners, not vendors. The transactional model is fading. Long-term alignment on risk and scale-up is the new expectation.
   3. Cost og goods is a clinical constraint now. Payers are entering the conversation earlier. COGs can’t be a commercialization afterthought anymore.
   4. Solid tumors and next-gen cell therapy are having a moment. The appetite for harder problems is real and competitive.
   5. Investors want plateforms and scalable infrastructure. Single-asset companies face a much tougher pitch environment.
   6. More partnerships, fewer big early VC rounds. Capital is being deployed more selectively than ever.

And the theme across all of it is: The science is there; Now it’s about execution and economics.